✦ LIBER ✦

Validity of biomarkers predicting onset or progression of nephropathy in patients with Type 2 diabetes: a systematic review

✍ Scribed by M. E. Hellemons; J. Kerschbaum; S. J. L. Bakker; H. Neuwirt; B. Mayer; G. Mayer; D. de Zeeuw; H. J. Lambers Heerspink; M. Rudnicki

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Asymmetric Dimethylarginine (ADMA) and P

✍ Heba Sayed Assal; Khaled Younes; Ahmed Alsayed; Nehal Hasan; Ahmed Ramadan Ali 📂 Article 📅 2009 🏛 Springer ⚖ 120 KB

Added value of novel circulating and gen

✍ Echouffo-Tcheugui, Justin B.; Dieffenbach, Sara D.; Kengne, Andre P. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 557 KB

Lipoprotein lipase gene variants and pro

✍ A. Solini; A. Passaro; P. Fioretto; M. Nannipieri; E. Ferrannini 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

Risk of progression of nephropathy in a

✍ S. Vupputuri; G.A. Nichols; H. Lau; P. Joski; M.L. Thorp 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 259 KB

Telomere length and progression of diabe

✍ F. Fyhrquist; A. Tiitu; O. Saijonmaa; C. Forsblom; P.-H. Groop; on behalf of the 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 310 KB

P259 DIFFERENCES IN BIOMARKERS OF OXIDAT

✍ B.M. Winklhofer-Roob; G. Faustmann; S. Fuchs; K. Öttl; A. Meinitzer; H. Sourij; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 45 KB